Posting of Circular to Shareholders
01 Dezembro 2010 - 10:05AM
UK Regulatory
TIDMCSC
RNS Number : 1722X
cScape Group PLC
01 December 2010
1 December 2010
cScape Group PLC
("Company" or "cScape")
Posting of Shareholder Circular and Notice of General Meeting
The board of directors ("Board") of cScape announces that a notice convening a
General Meeting forming part of a circular (the "Circular") was posted to
shareholders today. The General Meeting will be held at 10.00 a.m. on Thursday,
23 December 2010 at the offices of Smith & Williamson Corporate Finance Limited,
25 Moorgate, London EC2R 6AY, for the purpose of considering the following
resolutions:
1. a special resolution to effect the Sub-division, as defined in the
Circular;
2. a special resolution to effect the Consolidation, as defined in the
Circular;
3. an ordinary resolution authorising the Board to allot ordinary shares
in the Company; and
4. a special resolution giving the Board the power to disapply statutory
pre-emption rights in respect of allotments of ordinary shares for cash.
A copy of the Circular and the form of proxy are available on the Company's
website at www.cscapegroup.com and selected information extracted from the
Circular is set out below.
For further information, please contact:
Smith & Williamson Corporate Finance Limited
Tel: 020 7131 4000
Azhic Basirov / Siobhan Sergeant
The following information has been extracted without material adjustment from
the Circular.
The board of directors ("Board") of cScape Group PLC ("Company" or "cScape") is
proposing to make the change to the Company's capital structure, explained below
("Capital Reorganisation"). In addition, the Board is seeking the authority of
shareholders at a General Meeting, (notice of which is set out at the end of the
Circular), to allot new ordinary shares in the Company for cash pursuant to a
placing (the "Placing") to raise approximately GBP230,000 (net of expenses).
Set out below are further details of and reasons for the proposals.
Capital Reorganisation
The Company's ordinary shares of 10p each ("Ordinary Shares") are currently
trading at or below the nominal value. It is unlawful for the Company to allot
Ordinary Shares at a discount to their nominal value and this, therefore,
restricts the Company's ability to issue new Ordinary Shares, either for cash or
non-cash consideration, at or near to the current market price of an Ordinary
Share. Therefore, in order to undertake an equity fundraising or take advantage
of any future opportunities, the Board proposes a sub-division and redesignation
of the Ordinary Shares.
In addition, the Board believes that the Company's ability to attract new,
particularly institutional, investors would be enhanced and so the liquidity of
the Company's shares improved if, following a sub-division and redesignation of
the Ordinary Shares, there was a consolidation of the shares then comprised in
the Company's ordinary share capital into shares of a higher nominal amount.
It is not expected that the Capital Reorganisation will affect the continued
admission of the Company's shares to trading on the AIM market of the London
Stock Exchange.
Sub-division of Ordinary Shares
It is proposed that each of the 11,311,558 issued Ordinary Shares and the
6,688,442 unissued Ordinary Shares of 10p each be sub-divided into one share of
9p and one share of 1p. The redesignation of these shares will result in each
share of 9p becoming a deferred share ("Deferred Share") and each share of 1p
becoming a new ordinary share ("New Ordinary Share"), (together, the
"Sub-division").
Immediately following the Sub-division, every cScape shareholder ("Shareholder")
will hold one New Ordinary Share and one Deferred Share in place of every
Ordinary Share previously held.
The voting and other rights (including the rights to dividends) conferred on the
New Ordinary Shares will be identical to those currently attaching to the
existing Ordinary Shares as set out in the articles of association of the
Company.
The Deferred Shares will carry minimal rights and will have little or no
economic value. The Deferred Shares will have no rights to vote or to
participate in dividends and will carry limited deferred rights on any return of
capital (whether on a liquidation or otherwise). No application will be made
for the Deferred Shares to be admitted to trading on AIM. Further details of
the rights attached to the Deferred Shares are set out in Resolution 1 contained
in the notice of General Meeting.
Consolidation
Immediately following the Sub-division, it is proposed that there is a
reconsolidation of the Company's New Ordinary Shares (the "Consolidation"). The
Board believes that the Consolidation will increase liquidity of the Company's
shares.
The Consolidation would be on the basis that every 10 New Ordinary Shares
(whether issued or unissued) shall become one consolidated ordinary share of 10p
in the Company ("Consolidation Share"). Fractions of a Consolidation Share will
not be issued and accordingly individual Shareholders' entitlements will be
rounded down to the nearest whole number of Consolidated Shares. Fractional
entitlements will instead be aggregated and sold in the market for the benefit
of the Company.
The voting and other rights (including the rights to dividends) conferred on the
Consolidation Shares will be identical to those currently attaching to the
Ordinary Shares as set out in the articles of association of the Company.
Application will be made for the Consolidation Shares to be admitted to trading
on AIM following the approval of certain resolutions which will be put to the
Company's shareholders at a General Meeting to be held on 23 December 2010.
Subject to approval of the Capital Reorganisation at the General Meeting,
definitive share certificates in respect of the Consolidation Shares arising
from the Capital Reorganisation are expected to be despatched on or before 11
January 2011. For the avoidance of doubt, the Company will not issue share
certificates in relation to the New Ordinary Shares of 1p each. Definitive
share certificates for Consolidation Shares will not be despatched to those
shareholders who have previously elected to have their Ordinary Shares held in
uncertificated form. Instead the Consolidation Shares will be credited to such
Shareholders in uncertificated form through CREST. The new ISIN for the
Consolidation Shares will be GB00B4LFNL36, the new Sedol number will be B4LFNL3
and the ticker, CSC, remains unchanged.
Immediately following the passing of the resolutions to approve the Capital
Reorganisation at the General Meeting, share certificates in respect of existing
Ordinary Shares will cease to be valid for any purpose other than evidencing the
title of Shareholders to Deferred Shares. Prior to the despatch of definitive
share certificates, transfers of Consolidation Shares arising from the Capital
Reorganisation will be certified against the register.
The Placing
Subject to the approval by Shareholders of the resolutions to implement the
Capital Reorganisation and the Placing, the Board intends to place 357,143
Consolidation Shares (the "Placing Shares") with Keith Young, the Executive
Chairman of the Company, at a price of 70p per Placing Share (equivalent to the
closing mid-market price of an existing Ordinary Share as at 29 November 2010 of
7p). Following the issue of the Placing Shares, it is expected that Mr Young
will have a beneficial interest in 66.84% of the revised enlarged issued share
capital of the Company. Subject to the passing of each of the resolutions to be
proposed at the General Meeting, the Placing Shares are expected to be issued on
24 December 2010.
The Company has seen a significant shrinkage of new business opportunities in
the last few years, however the core of long established clients have continued
to hold up. The Board believes that the Company is now well positioned to take
advantage of the expected economic upturn. The Board acknowledges that the
business environment has been challenging and the containment of costs remains a
priority. Given the current situation, the Board believes that the Placing will
provide further stability to the Company. It is intended the proceeds of the
Placing will be used to fund the current working capital requirements of the
Company and potential future growth. The Placing will also give the Company the
flexibility to move quickly with regard to any future fundraising, should the
opportunity arise, following the Capital Reorganisation.
Authority to allot shares and power to disapply statutory pre-emption rights
In order to implement the Placing, the Company is seeking to renew the general
authority for the Board to allot shares and also to disapply the statutory
pre-emption rights in respect of allotments of shares for cash so that such
shares may be issued without first offering them to existing Shareholders on a
pro rata basis. These authorities will be valid until 23 March 2012 being the
date 15 months from the date of the relevant resolution.
The authority sought, other than with respect to rights issues and the Placing,
is limited to the issue of up to 74,415 Consolidation Shares, representing
approximately 5% of the revised issued share capital of the Company following
completion of the Capital Reorganisation.
Related Party Transaction
The Placing constitutes a related party transaction for the purposes of the AIM
Rules for Companies.
Robert Killick, the independent director of the Company, having consulted with
Smith & Williamson Corporate Finance Limited, in its capacity as nominated
adviser to the Company, considers the Placing to be fair and reasonable and in
the best interests of the Shareholders as a whole. In providing such advice
Smith & Williamson Corporate Finance Limited has taken into account the Mr
Killick's commercial consideration in respect of the Placing.
Share Options
It is not anticipated that the Capital Reorganisation will have any adverse
economic impact on the overall value which could be derived from the existing
options over the Company's shares.
Taxation
Shareholders are advised to consult an appropriate professional tax adviser in
relation to their tax position.
General Meeting
The proposed Capital Reorganisation and the authority to allot shares in the
Company will require the passing of certain resolutions by the Shareholders in
general meeting. A notice convening a General Meeting of the Company to be held
at the offices of Smith & Williamson Corporate Finance Limited, 25 Moorgate,
London EC2R 6AY at 10.00 a.m. on 23 December 2010, is set out at the end of the
Circular.
Recommendation
Your Board believes that the proposals described in this document are in the
best interests of the Company and its Shareholders and therefore the Directors
unanimously recommend you to vote in favour of the resolutions to be proposed at
the General Meeting, as they intend to do in respect of their own beneficial and
non-beneficial holdings, amounting in aggregate to 6,375,826 existing Ordinary
Shares, representing approximately 56.4 per cent of the Company's issued
ordinary share capital.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOEUARURRSAURAA
Cscape (LSE:CSC)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Cscape (LSE:CSC)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024